Version 2.80

Description

Leukoreduction is the removal of white blood cells (or leukocytes) from the blood or blood components supplied for blood transfusion. After the removal of the leukocytes, the blood product is said to be leukoreduced, or leukocyte-poor. It is theorized that transfusions that contain white blood cells may cause adverse effects through multiple mechanisms. White blood cells may themselves harbor infectious disease and some pathogens will be more concentrated in white blood cells than the rest of the blood product. It is also theorized that the donor white blood cells may suppress the recipient's immune system by interacting with it. A meta-analysis by Dr. Neil Blumberg et al (2007) found use of leukoreduced blood reduced the frequency of post-transfusion infection by 50%. Other scientific studies question the effectiveness of leukoreduction. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia , Leukoreduction

Basic Part Properties

Part Name
Leukocyte-poor
Part Display Name
Leukocyte-poor
Part Type
Fragments For Synonyms
Created On
2009-12-02

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP98246-9